Neurocrine Bio. (NBIX) PT Lowered to $140 at Truist Securities
Tweet Send to a Friend
(Updated - February 17, 2026 9:45 AM EST)
Truist Securities analyst Danielle Brill lowered the price target on Neurocrine ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Truist Securities analyst Danielle Brill lowered the price target on Neurocrine ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
